SJ-10542

N/A

Report date: 2026/01/20 18:01:41
NME

Base Information

Drug NameSJ-10542
Drug Alias NameSJ-10542
ClassificationSmall molecules > Proteolysis-Targeting Chimera (PROTAC)
Mechanisms of ActionTyrosine-protein kinase JAK3 degradersTyrosine-protein kinase JAK2 degraders
TargetsTyrosine-protein kinase JAK2Tyrosine-protein kinase JAK3
Therapy Area/IndicationsAutoimmune DiseasesLeukemia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesSt. Jude Children'S Research Hospital
China Registration ClassN/A

Develop Information

Active CompaniesSt. Jude Children'S Research Hospital
Inactive CompaniesN/A
Active IndicationsAutoimmune DiseasesLeukemia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A